Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SEE REMARKS

CHIEF MEDICAL OFFICER

CHIEF FINANCIAL OFFICER

Chief Medical Officer

See Remarks

Chief Financial Officer

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and product candidates for solid tumor programs. It has strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize CART-ddBCMA. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-16	Premium	sold	Premium	Premium	Premium	-
2024-04-16	Premium	acquired	Premium	Premium	Premium	-
2024-04-01	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-03-26	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-26	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-22	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-22	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-21	Premium	sold	Premium	Premium	Premium	-
2024-03-18	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2024-03-15	Premium	sold	Premium	Premium	Premium	-
2024-02-12	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-02-12	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-02-09	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-02-09	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-02-08	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-02-08	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-02-07	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-02-07	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-01-04	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-04	Premium	sold	Premium	Premium	Premium	See Remarks
2024-01-04	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-03	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-03	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-12-18	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

ACLX - Arcellx, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ACLX